CBD - Successful Verification for Oral Solution Products

Cannasouth Limited (NZX: CBD ) is pleased to announce the successful assessment of its first two CBD Oral Solutions products by the Medicinal Cannabis Agency (Agency).

CBD oral solutions constitute a major segment in the New Zealand and Australian medicinal cannabis markets. The verification by the Agency will enable the two CBD Oral Solution products to be launched immediately to the New Zealand market and positions Cannasouth to capture a significant share of the local market.

Cannasouth CEO Mark Lucas says “This product launch is a pivotal moment for both Cannasouth and the industry at large. It addresses a critical issue: affordability for New Zealand patients.

“Our merger with Eqalis Group has enabled us to leverage innovative technologies in medicinal cannabis processing, significantly reducing production costs and, by extension, prices to patients.

"The key to unlocking rapid growth in the medicinal cannabis sector lies in balancing quality, cost, and accessibility to meet or outperform the black market. This product verification is a significant stride toward that end."

Prior to the Medicinal Cannabis Scheme's new regulatory standards, Eqalis Pharmaceutical Ltd was one of the largest CBD product suppliers in New Zealand.

Chief Innovation Officer Greg Misson notes, "Our goal is to disrupt the industry's economics through technology and innovation. This will not only secure our market position but also deliver value to our shareholders and improve patient access to quality medicinal cannabis."

Cannasouth has a pipeline of new products in development and/or the assessment process, with verification of the first New Zealand dried flower product expected imminently.

A list of all medicinal cannabis products that meet the New Zealand minimum quality standard can be found here: https://www.health.govt.nz/our-work/regulation-health-and-disability-system/medicinal-cannabis-agency/medicinal-cannabis-agency-information-health-professionals/medicinal-cannabis-products-meet-minimum-quality-standard Cannasouth products will be added by the Ministry of Health in due course.

-ENDS-

•  NZX MAP_CBD_Successful Verification for Oral Solution Products

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

NZX welcomes capital markets reforms
CHI - Completion of retail bookbuild
With more banks deserting New Zealand, the consumer suffers
MEL - Neal Barclay steps down in 2025, Mike Roan appointed CE
December 12th Morning Report
December 11th Morning Report
December 10th Morning Report
CHATHAM ROCK CLOSES PRIVATE PLACEMENT OF SHARES
CVT - Accounting irregularities impact prior periods
December 9th Morning Report